Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary

TRACON Pharmaceuticals

14/05/2024 22:22

* TRACON Pharmaceuticals Inc  TCON.OQ  reported a quarterly
adjusted loss of $1.33​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of $-7.20.  The mean expectation of two analysts
for the quarter was for a loss of $1.19 per share. Wall Street
expected results to range from $-1.20 to $-1.18 per share.
    * Revenue was $100.00 thousand​; analysts expected zero. 
    * TRACON Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.33​.
    * The company reported a quarterly loss of $3.17 million.
    * TRACON Pharmaceuticals Inc shares had fallen by 76.5% this
quarter and lost 42.3% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $37.50 
This summary was machine generated from LSEG data May 14 at
09:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.19          -1.33          Missed
 Dec. 31 2023      -1.60          0.20           Beat
 Sep. 30 2023      -1.30          5.80           Beat
 Jun. 30 2023      -2.00          4.40           Beat